Investment Summary |
|
|---|---|
| Date | 2018-01-01 |
| Target | ByteDance |
| Sector | Internet Software and Services |
| Investor(s) |
KKR
Hony Capital |
| Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 510.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 266 of 483 |
| Sector (Internet Software and Services) | 18 of 36 |
| Type (Venture) | 23 of 35 |
| Country (China) | 20 of 28 |
| Year (2018) | 6 of 35 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-01 |
Headlands Research
Corte Madera, California, United States Headlands Research is a globally integrated site organization with a mission of profoundly impacting the clinical trials process. Headlands Research is comprised of the highest quality dedicated and embedded research centers across North America. Headlands Research was formed in 2018 and is based in Corte Madera, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-04 |
Imagine Learning
Tempe, Arizona, United States Imagine Learning operates a platform of digital and SaaS educational solution businesses and makes control investments in high potential businesses in the education industry. Imagine Learning was formed in 2010 and is based in Tempe, Arizona. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Hony Capital (Beijing) Co., Ltd. is a private equity firm focused on investment opportunities across China. The Firm targets buyouts and commercializations of Chinese state-owned enterprises as well as growth capital investments in rapidly-growing private Chinese companies. Hony's primary focus is within the construction materials, pharmaceuticals, construction machinery, retail, and consumer goods sectors, however, the firm will also consider opportunities in media/entertainment, financial services, energy, and resources. Hony is a long-term investor and is sponsored by Legend Holdings, parent of computer maker Lenovo amongst other properties. Hony Capital is located in Beijing, China.
| DEAL STATS | # |
|---|---|
| Overall | 38 of 41 |
| Sector (Internet Software and Services) | 1 of 1 |
| Type (Venture) | 5 of 7 |
| Country (China) | 30 of 32 |
| Year (2018) | 3 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-01 |
Honghe Renai Medical Group
Beijing, China Honghe Renai Medical Group is a platform that integrates investment and operations in the medical service sector. Through mergers and acquisitions of hospitals that meet leading standards, HCCL implements operational management and control that complement the characteristics of the Chinese medical service industry, improves hospital capabilities and service standards, and continuously enhances the comprehensive value of its hospitals. Honghe Renai Medical Group was founded in 2014 and is based in Beijing, China. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-01 |
I-MAB Biopharma
Shanghai, China I-MAB Biopharma is a global biotech company exclusively focused on developing innovative biologics of first-in-class or best-in-class potential in the therapeutic areas of immuno-oncology and autoimmune diseases. I-MAB Biopharma was founded in 2014 and is based in Shanghai, China. |
Buy | - |
